Hematological Malignancies Clinical Trials in Hangzhou, Zhejiang
3 recruitingHangzhou, Zhejiang, China
Showing 1–3 of 3 trials
Recruiting
Phase 1
The Study of ICP-248 in Patients With Mature B-cell Malignancies
Hematological Malignancies
Beijing InnoCare Pharma Tech Co., Ltd.191 enrolled22 locationsNCT05728658
Recruiting
18F-Pentixafor PET in Hematologic Malignancies
Hematological Malignancies
First Affiliated Hospital of Zhejiang University100 enrolled1 locationNCT07122674
Recruiting
Early Phase 1
A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies
Lymphoid Hematological MalignanciesRelapsed and Refractory
He Huang100 enrolled1 locationNCT04283006